Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Abnormal Baseline Brain Activity in Patients with Multiple Sclerosis With Simple Spinal Cord Involvement Detected by Resting-State Functional Magnetic Resonance Imaging.
Nitrous oxide induced myeloneuropathy: a case report.
Y-39983, a Selective Rho-Kinase Inhibitor, Attenuates Experimental Autoimmune Encephalomyelitis via Inhibition of Demyelination.
Altered collagen expression in jugular veins in multiple sclerosis.
MRI mean diffusivity detects widespread brain degeneration in multiple sclerosis.
FTY720 attenuates excitotoxicity and neuroinflammation.
Are more sphingosine 1-phosphate receptor agonists a better therapeutic option against multiple sclerosis?
Origin and differentiation of microglia.
The changing clinical course of multiple sclerosis: A matter of grey matter.
Systematic Review and Meta-Analysis of the Sero-Epidemiological Association between Epstein Barr Virus and Multiple Sclerosis.
A bird's-eye view of T cells during natalizumab therapy.
Profile of Circulatory Metabolites in a Relapsing-remitting Animal Model of Multiple Sclerosis using Global Metabolomics.
Scoring treatment response in patients with relapsing multiple sclerosis.
The flavonoid-enriched fraction AF4 suppresses neuroinflammation and promotes restorative gene expression in a mouse model of experimental autoimmune encephalomyelitis.
Neuroprotective agent riluzole potentiates postsynaptic GABA(A) receptor function.
Clinical predictors of disease progression in multiple sclerosis patients with relapsing onset in a nation-wide cohort.
Tonic spasms are a common clinical manifestation in patients with neuromyelitis optica.
Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota.
Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis.
Sphingolipids in ocular inflammation.
JC virus urinary excretion and seroprevalence in natalizumab-treated multiple sclerosis patients.
The benign form of multiple sclerosis. A study based on 241 cases seen within three years of onset and followed up until the tenth year or more of the disease. By Douglas McAlpine. From the Institute of Clinical Research, The Middlesex Hospital Medical Sc
Chronic cerebrospinal venous insufficiency and venous stenoses in multiple sclerosis.
[Progress of demyelinating animal models in the central nervous system].
MicroRNA regulation in experimental autoimmune encephalomyelitis in mice and marmosets resembles regulation in human multiple sclerosis lesions.

Pages